PRISM MarketView
@PrismMarketView
Followers
5K
Following
315
Media
4K
Statuses
11K
The PRISM stock indexes track small/micro-cap companies across a diverse spectrum of industries including clean energy, biotech and next-gen tech.
New York, NY
Joined May 2020
$JANX reported Q3 2025 results with $989M in cash, positioning the company for key data readouts on JANX007 and JANX008 in December and continued pipeline progress into 2026. https://t.co/j8ZdWscWYF
0
0
0
.@espn $DIS Teams Up with @DraftKings $DKNG for Exclusive Sports Betting Partnership After Ending Deal with PENN https://t.co/OdpykUbbH3
0
1
0
(NASDAQ: $ABAT) American Battery Technology Company is EPA-approved to recycle about 100,000 damaged lithium-ion battery modules from the largest U.S. cleanup after a 2025 fire, using its upgraded Nevada facility to recover valuable materials like lithium and cobalt, with an
prismmarketview.com
American Battery Technology Company (NASDAQ: ABAT), an integrated critical materials manufacturer and recycler, has been approved by the U.S. Environmental Prot
0
1
4
(NASDAQ: $CCLD) @CareCloud reported strong Q3 2025 results with $31.1 million revenue (up 9% YoY), $3.1 million GAAP net income, and $7.7 million adjusted EBITDA, raising full-year revenue guidance to $117–$119 million. https://t.co/9jS1qqiQez
prismmarketview.com
CareCloud, Inc. (Nasdaq: CCLD), a leader in healthcare technology and generative AI solutions, announced strong third quarter 2025 results, highlighted by highe
0
0
0
(NYSE: $JNJ) Johnson & Johnson’s Caplyta (lumateperone) gained FDA approval as an add-on therapy for adults with major depressive disorder, showing strong efficacy and a favorable safety profile with minimal side effects, offering a promising new treatment option for the large
0
0
0
.@WeRide_ai became the world’s first publicly traded robotaxi company with a dual listing in Hong Kong (HKEX: https://t.co/2yNBrDUyth) and on Nasdaq ( $WRD), raising over $300 million to expand its global autonomous fleet and accelerate commercialization, but shares dropped about
0
0
0
Texas voters approved Proposition 4, authorizing a historic $20 billion investment over 20 years to modernize the state’s water infrastructure. https://t.co/nHcbcnNIsp
prismmarketview.com
In a landmark move for infrastructure and environmental resilience, Texas voters have approved Proposition 4, authorizing up to $20 billion in long-term investm
0
0
0
$CHPT expands its public sector reach with a new Sourcewell contract, streamlining EV charging deployment for up to 50,000 public agencies across the U.S. and Canada. The award reinforces ChargePoint’s leadership in government EV infrastructure.
prismmarketview.com
ChargePoint Holdings, Inc., together with its subsidiaries, provides electric vehicle (EV) charging networks and charging solutions in the North America and Eur
0
0
1
Trump Set to Announce Deal to Offer Weight Loss Drugs for $149 on TrumpRX $NVO $LLY $DJT https://t.co/YcTPgFsqTv
0
0
0
PRISM Mid-Day Movers: Pharmaceuticals and Cannabis Lead Today’s Index’s @HepionPharma (NASDAQ: $HEPA) rose nearly 29%, and cannabis firm Fluent holding steady as it prepares for its Q3 earnings report. @fluentcannabis , Inc. (NASDAQ: $CNMTF) leads the cannabis index today
0
0
0
(NASDAQ: $GH) @GuardantHealth's new study validates its Reveal™ blood test for early and accurate monitoring of chemotherapy response in advanced breast cancer, showing 100% sensitivity and specificity in detecting recurrence, and offering oncologists a powerful non-invasive
0
1
0
Cannabis Beverages Emerge as a Disruptive Force in the Alcohol Market https://t.co/rf9LMVYaja
prismmarketview.com
A new study suggests that cannabis-infused beverages may be reshaping consumer habits—reducing alcohol use while improving sleep, mood, and stress levels. The
0
1
0
Annovis $ANVS hits 25% enrollment milestone, all 84 U.S. sites active in Phase 3 Alzheimer’s trial https://t.co/5zReRoBTup
prismmarketview.com
Annovis (ANVS) announced that its pivotal Phase 3 trial of buntanetap in early Alzheimer’s disease is now 25% complete, with all 84 clinical sites fully activ
0
1
0
AEye $LIDR scales Apollo lidar production to 60,000 units annually with institutional backing https://t.co/iojspTIlzi
prismmarketview.com
AEye, Inc. (NASDAQ: LIDR) has expanded its manufacturing capacity via a dedicated production line with LITEON Technology Corporation, supported by a new strateg
0
0
0
$QNRX reported strong Q3 progress with FDA Orphan Drug Designation for QRX003, $105.3M financing, and expansion of its clinical programs. Recruitment for pivotal Netherton Syndrome trials is expected to begin in Q4 2025. https://t.co/sh0h5lhOEm
0
0
1
Armis raises $435M pre-IPO round at $6.1B valuation as it eyes IPO https://t.co/4vxk5aRM7Q
prismmarketview.com
Armis announced it secured $435 million in a pre-IPO funding round, boosting its valuation to about $6.1 billion, as it gears up for an initial public offering.
0
1
0